Revolution Medicines (RVMD) Intangibles (2019 - 2026)

Revolution Medicines' Intangibles history runs 8 years deep, the most recent figure standing at $55.8 million for Q1 2026.

• On a quarterly basis, Intangibles fell 11.82% year-over-year to $55.8 million in Q1 2026; TTM through Mar 2026 was $55.8 million, a 11.82% decrease from a year earlier, with the FY2025 full-year figure at $55.8 million, down 1.54% from the prior year.
• Intangibles was little changed at $55.8 million in Q1 2026 per RVMD's latest filing, from $55.8 million in the prior quarter.
• Across five years, Intangibles topped out at $63.3 million in Q1 2022 and bottomed at $55.8 million in Q1 2023.
• The 5-year median for Intangibles is $57.7 million (2023), against an average of $58.3 million.
• Across the five-year window, Intangibles retreated 11.82% in 2023 and climbed 11.14% in 2025, its largest moves.
• Year by year, Intangibles stood at $58.8 million in 2022, then slipped by 1.82% to $57.7 million in 2023, then retreated by 1.85% to $56.7 million in 2024, then slipped by 1.54% to $55.8 million in 2025, then changed by 0.0% to $55.8 million in 2026.
• Per Business Quant, the three latest RVMD Intangibles figures stand at $55.8 million (Q1 2026), $55.8 million (Q4 2025), and $63.3 million (Q3 2025).